| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced it was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
As an Investor Catalyst Hub spoke, Daré gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.
"Earlier this year, I was honored to participate in the ARPA-H event where First Lady Jill Biden and ARPA-H announced ARPA-H's Sprint for Women's Health, an initiative intended to fundamentally change the trajectory of women's health care research and radically accelerate the next generation of discoveries. We look forward to the potential funding and ongoing opportunity to provide input into the priority area of women's health through our selection as an Investor Catalyst Hub spoke," said Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience.
Posted In: DARE
